Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias
Open Access
- 26 July 2022
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 8 (1) , e12330
Abstract
The health, well‐being, and financial security of Americans are greatly impacted by Alzheimer's disease. The forecast paints an upward trajectory with the number of Americans suffering from Alzheimer's disease and related dementia. To discuss the Alzheimer's crisis, The Senate Committee on Finance, Subcommittee on Health Care, held a hearing titled, “The Alzheimer's Crisis: Examining, Testing, and Treatment Pipelines and Fiscal Implications,” on December 16, 2020. Here, we summarize and expand on the discussion of the panel and its review of recent progress, ongoing challenges associated with Alzheimer's disease, and potential initiatives that promise to speed progress in developing treatments and improving care.Keywords
This publication has 11 references indexed in Scilit:
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementationThe Lancet Neurology, 2022
- Value-Generating Exploratory Trials in Neurodegenerative DementiasNeurology, 2021
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s diseaseNature Medicine, 2020
- Transition from physical to virtual visit format for a longitudinal brain aging study, in response to the Covid‐19 pandemic. Operationalizing adaptive methods and challengesAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisNeurology, 2019
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseNeurology, 2018
- Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosisAlzheimer's & Dementia, 2017
- The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelAlzheimer's & Dementia, 2016
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992